Necrotizing soft-tissue infections (NSTIs) are aggressive and deadly. Immediate surgical debridement is standard-of-care, but patients often present with non-specific symptoms, thereby delaying treatment. Because NSTIs cause microvascular thrombosis, we hypothesized that perfusion imaging using indocyanine green (ICG) would show diminished fluorescence signal in NSTI-affected tissues, particularly compared to non-necrotizing, superficial infections. Through a first-in-kind clinical study, we performed first-pass ICG fluorescence perfusion imaging of patients with suspected NSTIs. Early results support our hypothesis that ICG signal voids occur in NSTI-affected tissues and that dynamic contrast-enhanced fluorescence parameters reveal tissue kinetics that may be related to disease progression and extent.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078977PMC
http://dx.doi.org/10.1117/12.2648408DOI Listing

Publication Analysis

Top Keywords

first-in-kind clinical
8
clinical study
8
perfusion imaging
8
nsti-affected tissues
8
early identification
4
identification life-threatening
4
life-threatening soft-tissue
4
soft-tissue infection
4
infection dynamic
4
fluorescence
4

Similar Publications

Antimicrobial resistance (AMR) is a major cause of death worldwide, with 1.27 M direct deaths from bacterial drug-resistant infections as of 2019. Dissemination of multidrug-resistant (MDR) bacteria in the environment, in conjunction with pharmapollution by active pharmaceutical ingredients (APIs), create and foster an environmental reservoir of AMR.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists found a new medicine called NuP-4 that helps repair lung damage caused by viruses.
  • This medicine works by blocking a special protein called MAPK13, which has a big role in making lung cells change and heal after injury.
  • Researchers showed that NuP-4 can keep helping even after stopping the treatment, and it also helps reduce inflammation and make things better in cells from both mice and humans.
View Article and Find Full Text PDF

My 50-Plus Years of Academic Research Collaborations with Industry. A Retrospective.

J Org Chem

July 2024

Department of Chemistry, Université de Montréal, P.O. Box 6128, Succ. Centre-ville, Montréal, Québec, Canada H3C 3J7.

A retrospective is presented highlighting the synthesis of selected "first-in-kind" natural products, their synthetic analogues, structure elucidations, and rationally designed bioactive synthetic compounds that were accomplished because of collaborations with past and present pharmaceutical and agrochemical companies. Medicinal chemistry projects involving structure-based design exploiting cocrystal structures of small molecules with biologically relevant enzymes, receptors, and bacterial ribosomes with synthetic small molecules leading to marketed products, clinical candidates, and novel drug prototypes were realized in collaboration. Personal reflections, historical insights, behind the scenes stories from various long-term projects are shared in this retrospective article.

View Article and Find Full Text PDF

Significance: Necrotizing soft-tissue infections (NSTIs) are life-threatening infections with a cumulative case fatality rate of 21%. The initial presentation of an NSTI is non-specific, frequently leading to misdiagnosis and delays in care. No current strategies yield an accurate, real-time diagnosis of an NSTI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!